Drug Profile
Tulobuterol patch - Abbott/Nitto Denko Corporation
Alternative Names: HokunalinLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Hokuriku Seiyaku; Nitto Denko
- Developer Abbott Laboratories; Hokuriku Seiyaku; Maruho
- Class Antiasthmatics; Bronchodilators
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Asthma; Bronchitis; Emphysema